ResMed Expands Digital Health Leadership with Chronic Disease Technologies

2025-03-01 digitalcare

San Diego, Saturday, 1 March 2025.
ResMed is enhancing healthcare through telemonitoring and cloud-based solutions, improving care for sleep apnea and COPD patients globally.

Global Digital Health Innovation

ResMed has established itself as a pioneering force in digital health solutions, operating across more than 140 countries to transform chronic disease care [3]. The company’s cloud-connected medical devices and comprehensive out-of-hospital software platforms are revolutionizing treatment for sleep apnea and COPD patients, while empowering healthcare professionals with advanced telemonitoring capabilities [1]. Through their AirView platform, healthcare providers can remotely access sleep and respiratory therapy data, while patients engage with their treatment progress through the myAir app [1].

Market Growth and Impact

ResMed’s influence in the digital health space is reflected in their strong financial performance, with recent quarterly revenue reaching $1.3 billion and a 29% year-over-year growth in earnings per share [1]. The company’s impact extends beyond financial metrics, as demonstrated by their comprehensive 2025 Global Sleep Survey of over 30,000 respondents across 13 markets, which revealed critical insights about global sleep health challenges [1][3]. The survey highlighted that one in three people experience sleep difficulties three or more times weekly, emphasizing the growing need for innovative health solutions [3].

Technology Integration and Healthcare Outcomes

ResMed’s Global Technology Solutions (GTS) division is at the forefront of creating scalable and secure digital health platforms [4]. Their focus on innovative healthcare solutions is particularly relevant in the context of the expanding anti-snoring devices market, which is projected to grow from $0.91 billion in 2024 to $1.45 billion by 2029, representing a 9.8 percent CAGR [7]. The company’s emphasis on home care settings aligns with current healthcare trends, as patients increasingly prefer home sleep testing and advanced care devices [7].

Future Outlook and Challenges

Despite recent developments, including the cessation of Propeller Health operations as of February 21, 2025 [2], ResMed continues to strengthen its position in digital health innovation. The company’s commitment to improving chronic disease management is evident through their expansion of telemonitoring capabilities and cloud-connected solutions [1]. Their focus on addressing global sleep health challenges, particularly through digital solutions and remote monitoring, positions them well in an increasingly competitive healthcare technology landscape [3][4].

sources

digital health chronic disease